[Turk V, Turk B, Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J 2001; 20: 4629-33.10.1093/emboj/20.17.4629]Search in Google Scholar
[Kirschke H. Cathepsin H. In: Barret AJ, Rawlings ND, Woessner JF. Handbook of proteolytic enzymes. 2nd edition. London: Elsevier Academic Press; 2004. p. 1089-92.]Search in Google Scholar
[Kirschke H, Barrett AJ, Rawlings ND. Lysosomal cysteine proteases. 2nd edition. Oxford: Oxford University Press; 1998.]Search in Google Scholar
[Ritonja A, Popovic T, Kotnik M, Machleidt W, Turk V. Amino acid sequences of the human kidney cathepsins H and L. FEBS Lett 1988; 228: 341-5.10.1016/0014-5793(88)80028-0]Search in Google Scholar
[Vasiljeva O, Dolinar M, Turk V, Turk B. Recombinant human cathepsin H lacking the mini chain is an endopeptidase. Biochemistry 2003; 42: 13522-8.10.1021/bi035355k]Search in Google Scholar
[Nishimura Y, Kato K. Identification of latent procathepsin H in microsomal lumen: characterization of proteolytic processing and enzyme activation. Arch Biochem Biophys 1988; 260: 712-8.10.1016/0003-9861(88)90500-0]Search in Google Scholar
[Kominami E, Tsukahara T, Hara K, Katunuma N. Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages. FEBS Lett 1988; 231: 225-8.10.1016/0014-5793(88)80736-1]Search in Google Scholar
[Gocheva V, Chen X, Peters C, Reinheckel T, Joyce JA. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem 2010; 391: 937-45.10.1515/bc.2010.080]Search in Google Scholar
[Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL, et al. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene 2011; 30: 2057-69.10.1038/onc.2010.58521217776]Search in Google Scholar
[Ciric E, Sersa G. Radiotherapy in combination with vascular-targeted therapies. Radiol Oncol 2010; 44: 67-78.10.2478/v10019-010-0025-9342368422933894]Search in Google Scholar
[Gabrijelcic D, Svetic B, Spaic D, Skrk J, Budihna M, Dolenc I, et al. Cathepsins B, H and L in human breast carcinoma. Eur J Clin Chem Clin Biochem 1992; 30: 69-74.]Search in Google Scholar
[Schweiger A, Christensen IJ, Nielsen HJ, Sørensen S, Brünner N, Kos J. Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer. Int J Biol Markers 2004; 19: 289-94.10.1177/172460080401900406]Search in Google Scholar
[Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N, et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 1997; 3: 1815-22.]Search in Google Scholar
[Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, et al. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Biol Chem Hoppe Seyler 1996; 377: 385-90.10.1515/bchm3.1996.377.6.3858839984]Search in Google Scholar
[Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol 2008; 42: 69-81.10.2478/v10019-008-0006-4]Search in Google Scholar
[Sivaparvathi M, Sawaya R, Gokaslan ZL, Chintala SK, Rao JS. Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Lett 1996; 104: 121-6.10.1016/0304-3835(96)04242-5]Search in Google Scholar
[Friedrich B, Jung K, Lein M, Türk I, Rudolph B, Hampel G, et al. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur J Cancer 1999; 35: 138-44.10.1016/S0959-8049(98)00273-1]Search in Google Scholar
[Schweiger A, Staib A, Werle B, Krasovec M, Lah TT, Ebert W, et al. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking. Br J Cancer 2000; 82: 782-8.10.1054/bjoc.1999.0999237439810732746]Search in Google Scholar
[Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 2004; 279: 16178-84.10.1074/jbc.M31202920014766755]Search in Google Scholar
[Serveau-Avesque C, Martino MF, Hervé-Grépinet V, Hazouard E, Gauthier F, Diot E, et al. Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids. Biol Cell 2006; 98: 15-22.10.1042/BC2004051216354158]Search in Google Scholar
[Brasch F, Ten Brinke A, Johnen G, Ochs M, Kapp N, Müller KM, et al. Involvement of cathepsin H in the processing of the hydrophobic surfactantassociated protein C in type II pneumocytes. Am J Respir Cell Mol Biol 2002; 26: 659-70.10.1165/ajrcmb.26.6.474412034564]Search in Google Scholar
[D'Angelo ME, Bird PI, Peters C, Reinheckel T, Trapani JA, Sutton VR. Cathepsin H is an additional convertase of pro-granzyme B. J Biol Chem 2010; 285: 20514-9.10.1074/jbc.M109.094573289831320435891]Search in Google Scholar
[Lü J, Qian J, Keppler D, Cardoso WV. Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis. J Biol Chem 2007; 282: 22176-84.10.1074/jbc.M70006320017500053]Search in Google Scholar
[Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-94.10.1101/gad.10.13.15808682290]Search in Google Scholar
[Deng H, Ravikumar TS, Yang WL. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett 2009; 281: 220-31.10.1016/j.canlet.2009.02.046]Search in Google Scholar
[Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, et al. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol 2009; 218: 520-9.10.1002/path.2563]Search in Google Scholar
[Cui Y, Jean F, Thomas G, Christian JL. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J 1998; 17: 4735-43.10.1093/emboj/17.16.4735]Search in Google Scholar
[Degnin C, Jean F, Thomas G, Christian JL. Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4. Mol Biol Cell 2004; 15: 5012-20.10.1091/mbc.e04-08-0673]Search in Google Scholar
[Goldman DC, Hackenmiller R, Nakayama T, Sopory S, Wong C, Kulessa H, et al. Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity. Development 2006; 133: 1933-42.10.1242/dev.02368]Search in Google Scholar
[Schweiger A, Stabuc B, Popovíc T, Turk V, Kos J. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. J Immunol Methods 1997; 201: 165-72.10.1016/S0022-1759(96)00218-9]Search in Google Scholar
[Jevnikar Z, Obermajer N, Bogyo M, Kos J. The role of cathepsin X in the migration and invasiveness of T lymphocytes. J Cell Sci 2008; 121: 2652-61.10.1242/jcs.02372118664495]Search in Google Scholar
[Angliker H, Wikstrom P, Kirschke H, Shaw E. The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents. Biochem J 1989; 262: 63-8.10.1042/bj262006311332292818577]Search in Google Scholar
[Obermajer N, Svajger U, Bogyo M, Jeras M, Kos J. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X. J Leukoc Biol 2008; 84: 1306-15.10.1189/jlb.0508285325284318701767]Search in Google Scholar
[Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22: 233-41.10.1080/0897719041233127989015621726]Search in Google Scholar
[Kominami E, Tsukahara T, Bando Y, Katunuma N. Distribution of cathepsins B and H in rat tissues and peripheral blood cells. J Biochem 1985; 98: 87-93.10.1093/oxfordjournals.jbchem.a135277]Search in Google Scholar
[del Re EC, Shuja S, Cai J, Murnane MJ. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas. Br J Cancer 2000; 82: 1317-26.10.1054/bjoc.1999.1098]Search in Google Scholar
[Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ. Analysis of a truncated form of cathepsin H in human prostate tumor cells. J Biol Chem 2002; 277: 11533-8.10.1074/jbc.M109557200]Search in Google Scholar
[Cui Y, Hackenmiller R, Berg L, Jean F, Nakayama T, Thomas G, et al. The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev 2001; 15: 2797-802.10.1101/gad.940001]Search in Google Scholar
[Takahashi T, Dehdarani AH, Tang J. Porcine spleen cathepsin H hydrolyzes oligopeptides solely by aminopeptidase activity. J Biol Chem 1988; 263: 10952-7.10.1016/S0021-9258(18)38062-1]Search in Google Scholar
[Ohkawara B, Iemura S, ten Dijke P, Ueno N. Action range of BMP is defined by its N-terminal basic amino acid core. Curr Biol 2002; 12: 205-9.10.1016/S0960-9822(01)00684-4]Search in Google Scholar
[Zhou Z, Sun L, Wang Y, Wu Z, Geng J, Miu W, et al. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother Radiopharm 2011; 26: 77-83.10.1089/cbr.2010.085721355779]Search in Google Scholar
[Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011; 140: 297-309.10.1053/j.gastro.2010.10.00520951698]Search in Google Scholar
[Goldman DC, Bailey AS, Pfaffle DL, Al Masri A, Christian JL, Fleming WH. BMP4 regulates the hematopoietic stem cell niche. Blood 2009; 114: 4393-401.10.1182/blood-2009-02-206433277712419759357]Search in Google Scholar
[Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, Lah TT. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids. Radiol Oncol 2011; 45: 102-15.10.2478/v10019-011-0015-6342373122933943]Search in Google Scholar